StocksMedium•3 November 2026•
1 min read
Fresenius Medical Lowers Upper End of 2026 Profit Guidance
Key Facts
1Fresenius Medical has lowered the upper end of its profit guidance for the 2026 fiscal year.
Fresenius Medical has lowered the upper end of its profit guidance for the 2026 fiscal year. Reuters reported that the company adjusted its financial outlook, signaling a more conservative expectation for its maximum profit potential during that period.
FSNUY closed at $13.56 on November 2, 2026, with the stock reaching a day high of $13.71 and a low of $13.47. The downward revision to the top end of the profit range reflects updated forward-looking guidance regarding the company's performance expectations.